Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T14:10:49.820Z.
Calculation as of: 2026-10-06T14:10:49.820Z.
Quote observation: 2026-10-06T14:10:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f6ebf84f3f464cb4543e326b3b96959337d3a5891063dc6ef63f2f1a4491a7a3
PE RATIO
N/A
Market Cap
$1.45M
PE Ratio
N/A
TTM Avg
21295.08
3Y Avg
21295.08
5Y Avg
21295.08
Market Cap
$1.46M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | $1.38M | N/A | N/A | N/A | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.45M | N/A | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.31M | N/A | N/A | N/A | N/A |
| Curis, Inc. (CRIS)vs › | $1.46M | N/A | 47.01 | 47.01 | 34.74 |
| INVO Fertility, Inc. (IVF)vs › | $1.45M | N/A | 21295.08 | 21295.08 | 21295.08 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | N/A | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.16M | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.19M | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | N/A | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.10M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$3.57
Forward EPS (Est.)
$-88.56
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
